Evolva, the Swiss pharmaceutical group, is expanding its innovative nutritional ingredients portfolio with the acquisition of R&D partner Abunda Nutrition, the US food ingredients business. Evolva and San Francisco-based Abunda
Evolva, the Swiss pharmaceutical group, is expanding its innovative nutritional ingredients portfolio with the acquisition of R&D partner Abunda Nutrition, the US food ingredients business. Evolva and San Francisco-based Abunda